MicroSynbiotiX

About:

MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish.

Website: https://www.microsynbiotix.com

Twitter/X: microsynbiotix

Top Investors: Enterprise Ireland, SOSV, The Yield Lab Europe, RebelBio, Alimentos Ventures

Description:

MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish. With MicroSynbiotiX's advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. By using microalgae as an oral delivery vehicle, MicroSynbiotiX substantially cuts the labor and post-processing production costs, allowing the production of effective vaccines that are much more affordable and user-friendly. The technology can eliminate the use of antibiotics, reduce fish mortality rates in aquaculture farms, prevent bacterial and viral diseases from wiping out entire fish stocks, and improve global food security. MicroSynbiotiX was founded on 2016 and is headquartered in Cork City, Ireland.

Total Funding Amount:

$1.62M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cork, Cork, Ireland

Founded Date:

2016-01-01

Contact Email:

info(AT)microsynbiotix.com

Founders:

Antonio Lamb, Sebastian Cocioba, Simon Jegan Porphy

Number of Employees:

1-10

Last Funding Date:

2019-10-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai